← Eichor
Condition: Stargardt Disease Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Stargardt Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degener
Phase N/A · 1 location(s) · Ray Therapeutics, Inc. · NCT06375239An Clinical Study Evaluating the Safety, Tolerability, and efficAcy of HG005 in StaRgardT Disease
EARLY_Phase 1 · 1 location(s) · HuidaGene Therapeutics Co., Ltd. · NCT07063251Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
Phase N/A · 8 location(s) · Ascidian Therapeutics, Inc · NCT06445322Phase 1 Study of C.001 in Retinal Degeneration
Phase 1 · 1 location(s) · Cellio Therapeutics Inc · NCT07594236Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
Phase 1/Phase 2 · 10 location(s) · Ascidian Therapeutics, Inc · NCT06467344Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients
Phase 1/Phase 2 · 3 location(s) · Ray Therapeutics, Inc. · NCT07439887Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal
Phase N/A · 1 location(s) · Ray Therapeutics, Inc. · NCT07502664A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)
Phase 1/Phase 2 · 8 location(s) · AAVantgarde Bio Srl · NCT07161544An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Au
Phase N/A · 20 location(s) · Splice Bio · NCT06435000A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
Phase N/A · 12 location(s) · Astellas Pharma Global Development, Inc. · NCT07425574Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene
Phase N/A · 1 location(s) · National Eye Institute (NEI) · NCT01145196Safety and Preliminary Efficacy of VG801 in Patients With ABCA4 Mutation-associated Retinal Dystrophy (Stargardt Disease
Phase 1/Phase 2 · 1 location(s) · VeonGen Therapeutics GmbH · NCT07002398A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficac
Phase 1/Phase 2 · 5 location(s) · Splice Bio · NCT06942572Study of ALK-001 on the Progression of Stargardt Disease
Phase 3 · 5 location(s) · Alkeus Pharmaceuticals, Inc. · NCT07419334Restoration of Central Vision With PRIMA in Patients With Photoreceptor Degeneration
NA · 1 location(s) · Science Corporation · NCT07266584Rod and Cone Mediated Function in Retinal Disease
Phase N/A · 1 location(s) · National Eye Institute (NEI) · NCT02617966A Study of DC6001 Tablet in Healthy Chinese Adult Subjects
Phase 1 · 1 location(s) · Heronova Pharmaceuticals · NCT07417566A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT
Phase N/A · 1 location(s) · Nanoscope Therapeutics Inc. · NCT06805474Inherited Retinal Degenerative Disease Registry
Phase N/A · 1 location(s) · Foundation Fighting Blindness · NCT02435940Stem Cell Ophthalmology Treatment Study II
NA · 4 location(s) · MD Stem Cells · NCT03011541The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration
Phase 1 · 1 location(s) · University of Rochester · NCT06319872
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.